(Q47850962)

6 February 2018

title

Dual loss of succinate dehydrogenase (SDH) and complex I activity is necessary to recapitulate the metabolic phenotype of SDH mutant tumors (English)

1 reference

6 February 2018

author

Catherine Verfaillie

14

1 reference

6 February 2018

Sarah-maria Fendt

16

1 reference

6 February 2018

Gianmarco Rinaldi

object named as

Gianmarco Rinaldi

2

0 references

Doriane Lorendeau

object named as

Doriane Lorendeau

1

0 references

Ruben Boon

object named as

Ruben Boon

3

0 references

author name string

Pieter Spincemaille

4

1 reference

6 February 2018

Kristine Metzger

5

1 reference

6 February 2018

Christian Jäger

6

1 reference

6 February 2018

Stefan Christen

7

1 reference

6 February 2018

Xiangyi Dong

8

1 reference

6 February 2018

Sabine Kuenen

9

1 reference

6 February 2018

Karin Voordeckers

10

1 reference

6 February 2018

Patrik Verstreken

11

1 reference

6 February 2018

David Cassiman

12

1 reference

6 February 2018

Pieter Vermeersch

13

1 reference

6 February 2018

Karsten Hiller

15

1 reference

6 February 2018

publication date

12 November 2016

1 reference

6 February 2018

published in

Metabolic Engineering

1 reference

6 February 2018

volume

43

1 reference

6 February 2018

issue

Pt B

1 reference

6 February 2018

page(s)

187-197

1 reference

6 February 2018

Depression of neuron responses to acetylcholine by combined application of norepinephrine and substrates of the tricarboxylic acid cycle

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Elementary metabolite units (EMU): a novel framework for modeling isotopic distributions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Late-onset optic atrophy, ataxia, and myopathy associated with a mutation of a complex II gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

An Essential Role of the Mitochondrial Electron Transport Chain in Cell Proliferation Is to Enable Aspartate Synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Succinate in dystrophic white matter: a proton magnetic resonance spectroscopy finding characteristic for complex II deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

A roadmap for interpreting (13)C metabolite labeling patterns from cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Deficiency in complex II of the respiratory chain, presenting as a leukodystrophy in two sisters with Leigh syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Pheochromocytoma and paraganglioma: molecular testing and personalized medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

SDHA is a tumor suppressor gene causing paraganglioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Breast Cancer-Derived Lung Metastases Show Increased Pyruvate Carboxylase-Dependent Anaplerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

The mTORC1/S6K1 pathway regulates glutamine metabolism through the eIF4B-dependent control of c-Myc translation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Organ-Specific Cancer Metabolism and Its Potential for Therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Toward an improved definition of the genetic and tumor spectrum associated with SDH germ-line mutations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

The Warburg effect is genetically determined in inherited pheochromocytomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Reductive glutamine metabolism is a function of the α-ketoglutarate to citrate ratio in cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Correction of 13C mass isotopomer distributions for natural stable isotope abundance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Biochemical analyses of the electron transport chain complexes by spectrophotometry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

MetaboliteDetector: comprehensive analysis tool for targeted and nontargeted GC/MS based metabolome analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

The role of complex II in disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Structural and computational analysis of the quinone-binding site of complex II (succinate-ubiquinone oxidoreductase): a mechanism of electron transfer and proton conduction during ubiquinone reduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Current and future treatments for malignant pheochromocytoma and sympathetic paraganglioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Metabolic control of signalling pathways and metabolic auto-regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Metformin therapy in a transgenic mouse model of Huntington's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Evaluation of 13C isotopic tracers for metabolic flux analysis in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Atpenins, potent and specific inhibitors of mitochondrial complex II (succinate-ubiquinone oxidoreductase).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Oncometabolites-driven tumorigenesis: From genetics to targeted therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Oncometabolites: tailoring our genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Role of microenvironment on neuroblastoma SK-N-AS SDHB-silenced cell metabolism and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

SDHB-Deficient Cancers: The Role of Mutations That Impair Iron Sulfur Cluster Delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Rapid, complete and large-scale generation of post-mitotic neurons from the human LUHMES cell line.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Crystal structure of mitochondrial respiratory membrane protein complex II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

(1)H NMR based metabolomics of CSF and blood serum: a metabolic profile for a transgenic rat model of Huntington disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Metabolic reprogramming for producing energy and reducing power in fumarate hydratase null cells from hereditary leiomyomatosis renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Quantifying reductive carboxylation flux of glutamine to lipid in a brown adipocyte cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

An elementary metabolite unit (EMU) based method of isotopically nonstationary flux analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

Kinetic flux profiling for quantitation of cellular metabolic fluxes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2016.11.005

10.1016/J.YMBEN.2016.11.005

7 January 2021

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018